Jardine, Ian (Thermo Fisher 200803 VP Global Research + Develop) |
Research & Development Manager |
Thermo Fisher (Group) |
United States (USA) |
Jaskolski, Janik (Semalytix 201505– Managing Director + Co-Founder) |
Managing Director |
Semalytix GmbH |
Germany |
Jazdowski, Oscar (SVB 202101 General Manager Silicon Valley Bank German Branch) |
General Manager (management) |
SVB (Silicon Valley Bank) (Group) |
Germany |
Jean-Mairet, Joël (Ysios Capital 201206) |
n. a. |
Ysios Capital (Group) |
Spain (España) |
Jeddeloh, Jeffrey (DNA Script 201811– VP BusDev + Commercial Strategy before Roche + Orion Genomics) |
Business Development Manager / Strategy Manager |
DNA Script (Group) |
United States (USA) |
Jeffreys, Hayden (Lumora 2013– Commercial Director) |
Chief Commercial Officer (CCO) |
Erba Diagnostics Mannheim (Group) |
United Kingdom (GB) |
Jegge, Gabriele (Medigene 201612 Investor + Public Relations) |
Public Relations Manager / Investor Relations Manager |
Medigene (Group) |
Germany |
Jeggle, Helmut (STRÜNGMANN Group + before Hexal + scine 2009 Apceth Managing Director CFO) |
Investment Manager |
STRÜNGMANN Group (family Strüngmann) |
Germany |
Jehle, Heinrich (3a-diagnostics 201910– Managing Director) |
Managing Director |
3a-Diagnostics GmbH |
Germany |
Jehle, Regina (Abivax 201912– Director of Communications before BioNTech 2014– 2019) |
Public Relations Manager / Investor Relations Manager |
Abivax (Group) |
France |
Jeker, Rene (Bruker Corp 201004 Managing Director Bruker BioSpin AG Switzerland) |
Managing Director |
Bruker (Group) |
Switzerland |
Jelic-Masterton, Gavin (Finox AG 201307– CEO joined 2/13 as SVP Marketing + Comercial before Ferring + Merck Serono) |
Chief Executive Officer (CEO) |
Finox AG (Finox Biotech) |
Switzerland |
Jelich, Klaus (Bayer 201012 Site Manager Bayer Healthcare Wuppertal) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
Jenckel, Ludolf (Atlas MAT) |
Chief Executive Officer (CEO) |
Thermo Fisher (Group) |
Germany |
Jenkins, Annalisa (TransCelerate BioParma 201402 Chair of Board of Directors before Merck Serono + BMS) |
Research & Development Manager |
TransCelerate BioPharma Inc. |
United States (USA) |
Jenkins, Richard (Silence Therapeutics 201806– Head of Clinical Development before Takeda + GSK + Roche) |
Chief Medical Officer (CMO) |
Silence Therapeutics (Group) |
United Kingdom (GB) |
Jenn, Stephan (Novalix 201011 President) |
President/Director/Head Business Group/Unit/Division |
Novalix (Group) |
France |
Jenne, Andreas (RSP Systems 201805– CEO before NEO New Oncology + Blackfield + Kinaxo) |
Chief Executive Officer (CEO) |
RSP Systems A/S |
Denmark |
Jennewein, Amélie (Jennewein Biotechnologie GmbH Co-Founder) |
Company Founder |
Chr. Hansen (Group) |
Germany |
Jennewein, Klaus (Jennewein Biotechnologie GmbH 201512 Managing Director + Co-Founder) |
Managing Director |
Chr. Hansen (Group) |
Germany |
Jennewein, Stefan (Jennewein Biotechnologie GmbH Co-Founder) |
Company Founder |
Chr. Hansen (Group) |
Germany |
Jenni, Mario (Bio-Technopark Schlieren 201104 Managing Director) |
Managing Director |
Bio-Technopark Schlieren-Zürich |
Switzerland |
Jennings, Gary (Jado 2007 continued as CSO before co-founder + CEO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Jado Technologies GmbH |
Germany |
Jennings, Lisa K. (CirQuest Labs 2008– CEO + Owner + Founder + Prof at Univ Tennessee Health Science Center) |
Chief Executive Officer (CEO) |
MLM Medical Labs (Group) |
United States (USA) |
Jensen, Derek (Hamilton 201303 HPLC product specialist at Hamilton Company) |
Product Manager (personnel) |
Hamilton (Group) |
United States (USA) |
Jensen, J. Chris (Speedel 200705 Head Scientific Affairs) |
n. a. |
Novartis (Group) |
Switzerland |
Jensen, Johannes (Novo Group 200501 VP of Novo Nordisk Biotech Fund) |
Investment Manager |
Novo Group (Group) |
Denmark |
Jentner, Jürgen (HighQu GmbH 201504 Managing Director) |
Managing Director |
HighQu GmbH |
Germany |
Jentsch, Stefan |
n. a. |
University of Heidelberg (Ruperto Carola) |
Germany |
Jeradi, Ahmad (Adanced Technology Company 201207 VP Strategy Business Dev elopment / M&A International Operations) |
Business Development Manager / Strategy Manager |
Advanced Technology Company K.S.C. (ATC) |
Kuwait |
Jessen, Timm-Heinrich (Topas Therapeutics 201510–202007 Managing Director before Bionamics + Scienamics RESIGNED 7/20) |
Managing Director |
Topas Therapeutics GmbH |
Germany |
Jiali, Luo (Boehringer Ingelheim 201705 General Manager of BI Biopharmaceuticals (China) Co Ltd) |
General Manager (management) |
Boehringer Ingelheim (Group) |
China |
Jiang, Frank (CStone 201905 CEO) |
Chief Executive Officer (CEO) |
CStone Pharmaceuticals (HKEX:2616) |
China |
Jiang, Hui (BGI 202002 COO of MGI) |
Chief Operating Officer (COO) |
Sophia Genetics (Group) |
Switzerland |
Jiang, Wei (Bayer 202008 EVP + President of Bayer Pharma Region China + APAC) |
Regional manager |
Bayer (Group) |
China |
Jimenez, Joseph (Joe) (Novartis 201002–CEO before since 200704 CEO Consumer Health) |
Chief Executive Officer (CEO) |
Novartis (Group) |
Switzerland |
Joecker, Anika (CLC bio 201109 Bioinformatics Specialist) |
n. a. |
Qiagen (Group) |
Denmark |
Johann, Peter (NGN Capital 200502 Managing General Partner) |
Managing Partner (investment firm) |
NGN Capital (Group) |
United States (USA) |
John, Llewellyn (Nova Capital 200601 Accociated Partners before Deloitte) |
n. a. |
Nova Capital (Group) |
United Kingdom (GB) |
Johnsen, Bent (Emperra GmbH 201706– Managing Director + CEO) |
Managing Director |
Emperra GmbH E-Health Technologies |
Germany |
Johnson, Eric R. (JSR Corp 201706 President of JSR Life Sciences division) |
President/Director/Head Business Group/Unit/Division |
JSR Corporation (Group) |
Japan |
Johnson, Jason (Illumina 201703 Senior Director for Arrays) |
Product Manager (personnel) |
Illumina (Group) |
United States (USA) |
Johnson, Kevin Stuart (Medicxi Ventures 201602– General Partner before Index Ventures + PanGenetics + CAT) |
General Partner (venture partner) |
Medicxi Ventures (formerly Index Ventures Life Sciences) |
United Kingdom (GB) |
Johnson, Noel L. (Sequana Medical 201404 CEO) |
Chief Executive Officer (CEO) |
Sequana Medical (Group) |
Switzerland |
Johnson, Tim (TJ) (High Throughput Genomics 200811 CEO before Ventana Medical) |
Chief Executive Officer (CEO) |
HTG (Group) |
United States (USA) |
Johnson, Wendy (Gemini Advisors 201503 Managing Director before ProQuest Investments + Aires Pharmaceuticals) |
Managing Director |
|
|
Johnson, Zoë (iOnctura 2018– promoted to CSO before UCB + Merck + Novimmune) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
iOnctura (Group) |
Switzerland |
Johnstone, Craig (Evotec 201901– COO) |
Chief Operating Officer (COO) |
Evotec (Group) |
Germany |
Jones, Jonathan (Waters 200403– Waters Manchester before Univ Swansea) |
Technical Manager |
Waters (Group) |
United States (USA) |
Jones, Lee (Rebiotix 201804 CEO + Founder) |
Chief Executive Officer (CEO) |
Ferring (Paulsen Foundation) (Group) |
United States (USA) |
Jones, Richard (Shield Therapeutics 201105– CFO before Investec Investment Banking Director + Head of Healthcare) |
Chief Financial Officer (CFO) |
Iron Therapeutics (Switzerland) AG |
Switzerland |
Jones, Steven C. (NeoGenomics 201703 EVP + Director Investor Relations) |
n. a. |
NeoGenomics Inc. (Nasdaq: NEO) |
United States (USA) |
Jones, Trevor (Sigma-Aldrich 201412 VP Analytical business 200708 Euro Marketing Manager) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
United States (USA) |
Jonischkeit, Barbara (BIOPRO 201504 Head of Communications) |
Public Relations Manager / Investor Relations Manager |
Baden-Württemberg (govt region) |
Germany |
Joore, Jos (Mimetas 201410 CBO + Co-Founder) |
Chief Business Officer (CBO) |
Mimetas B.V. |
Netherlands |
Joos, Thomas (NMI) |
n. a. |
University of Tübingen (Eberhard-Karls-Universität) |
Germany |
Jordan, Alfons (Ionicon 201103– VP of Ionicon US Inc + co-founder of Ionicon Austria) |
President/Director/Head Business Group/Unit/Division |
Ionicon (Group) |
United States (USA) |
Jordan, Andreas (MagForce 201110– interim CEO) |
Chief Executive Officer (CEO) |
MagForce (Group) |
Germany |
Jordan, Foster (Charles River 201304 SVP Endotoxin + Microbial Detection) |
President/Director/Head Business Group/Unit/Division |
Charles River (Group) |
United States (USA) |
Jordan, Pablo (Definiens 201310– VP Business Development Clinical Digital Pathology before bioMérieux + Ventana) |
Business Development Manager / Strategy Manager |
AstraZeneca (Group) |
Germany |
Jordens, Jan (DSM 201606 at DSM Resolve) |
Laboratory Manager (industry) |
DSM (Group) |
Netherlands |
Jornitz, Maik (Sartorius 200909 VP Marketing Fermentation Technology) |
Sales Manager / Marketing Manager |
Sartorius (Group) |
Germany |
Jornod, Etienne (Galenica 201505 Executive Chairman) |
Chief Executive Officer (CEO) |
Galenica (Group) |
Switzerland |
Jose, Joachim (Autodisplay Biotech GmbH 201112 Managing Director) |
Managing Director |
Autodisplay Biotech GmbH |
Germany |
Jose, Simon (Idorsia 201812– Chief Commercial Officer before GSK) |
Chief Commercial Officer (CCO) |
Idorsia (Group) |
Switzerland |
Jost, Sonja (DexLeChem GmbH 201502 Managing Director) |
Managing Director |
DexLeChem GmbH |
Germany |
Jostes, Birgit (Qiagen 200704 Senior Global Director Corp Marketing + Strategy) |
Sales Manager / Marketing Manager |
Qiagen (Group) |
Germany |
Joyce, Thomas P., Jr. (Tom) (Danaher 201503– promoted CEO before 25 years at Danaher) |
Chief Executive Officer (CEO) |
Danaher (Group) |
United States (USA) |
Juhl, Hartmut (Indivumed 200701 CEO + founder) |
Chief Executive Officer (CEO) |
Indivumed (Group) |
Germany |
Jung, Christian Billy (High-Tech Gründerfonds 201305 Investment Manager) |
Board member, executive |
Loqus23 Therapeutics Ltd. |
United Kingdom (GB) |
Jung, Gundram (Univ Tübingen 201205 Professor at Institute of Immunology) |
Professor |
University of Tübingen (Eberhard-Karls-Universität) |
Germany |
Jung, Marion (ChromoTek GmbH 201203 Managing Director) |
Managing Director |
Proteintech (Group) |
Germany |
Jung, Wulf-Ingo (Bruker 201009 Managing Director of Bruker BioSpin GmbH) |
Managing Director |
Bruker (Group) |
Germany |
Jungbauer, Alois (Austrian Centre of Industrial Biotechnology) |
Professor |
ACIB GmbH – Austrian Centre of Industrial Biotechnology |
Austria |
Jungbluth, Catherine (Aachen (city govt) 201306 AGIT mbH) |
n. a. |
Aachen (govt city) |
Germany |
Junge, Benjamin (Biotecon 200908 Product Manager Pharma Hygiene) |
Sales Manager / Marketing Manager |
EW Group (Erich Wesjohann) (Group) |
Germany |
Jungnelius, Jarl Ulf (Noxxon 201702– CMO + Vaximm 201605– CMO before Celgene + Pfizer + Lilly + Karolinska Hospital) |
Chief Medical Officer (CMO) |
Vaximm (Group) |
Switzerland |
Junius, Daniel (ImmunoGen 200901 CEO before COO) |
Chief Executive Officer (CEO) |
ImmunoGen Inc. (Nasdaq: IMGN) |
United States (USA) |
Jurgeit, Andreas (Merck (DE) 201706 Investment Director at Merck Ventures) |
Investment Manager |
Merck (DE) (Group) |
Netherlands |
Jurinke, Christian (Stratec 201110 Marketing Manager at Stratec Molecular before Caprotec before Sequenom) |
Sales Manager / Marketing Manager |
Stratec (Group) |
Germany |
Jury, Karin (AbD Serotec 200606 Key Account Manager) |
Sales Manager / Marketing Manager |
Bio-Rad (Group) |
Germany |
Juschitz, Peter (Endress+Hauser 201510– COO at Analytik Jena before AHT Cooling Systems + Epcos Kft) |
Chief Commercial Officer (CCO) |
Endress+Hauser (Group) |
Germany |
Just Larsen, Philip (Grünenthal 201804– CSO before Sanofi Ffm + Eli Lilly + Novo Nordisk) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Grünenthal (Group) |
Germany |
Just, Enrico (bio.logis Genomic Healthcare 201409– Managing Director) |
Managing Director |
bio.logis Genomic Healthcare GmbH |
Germany |
Jünger, Katharina (TeleClinic 2015– Managing Director + Co-Founder) |
Managing Director |
Zur Rose Group (Group) |
Germany |
Jürgens, Hartmut (MeVis) |
n. a. |
Varian Medical Systems (Group) |
Germany |
Jürgens, Hendrik (Omni Life Sciences 201312 Managing Director) |
Managing Director |
Omni Life Science (OLS) (Group) |
Germany |
Jürgens, Horst (Omnilab (D) 200903 Managing Director) |
Managing Director |
Omnilab (DE) (Group) |
Germany |
Jürgens, Joachim (Omnilab (DE) 200903 Managing Director) |
Managing Director |
Omnilab (DE) (Group) |
Germany |
Jürgens-Pieper, Renate (Bremen 200811 Wissenschaftssenatorin) |
n. a. |
Bremen (govt region) |
Germany |
Jüterbock, Wolf-Rainer |
n. a. |
Eurofins (Group) |
Germany |
Jäger, Elke (Univ Frankfurt 200802 Prof) |
Professor |
University of Frankfurt (Goethe-Universität) |
Germany |
Jäger, Karl-Erich (Univ Düsseldorf 201201 Director Institute for Molecular Enzyme Technology) |
Professor |
University of Düsseldorf, Institute for Molecular Enzyme Technology (IMET) at FZ Jülich |
Germany |
Jäger, Wolfgang (Biotechrabbit 2013– Head of Sales before GE Healthcare / Biacore) |
Sales Manager / Marketing Manager |
Biotechrabbit (Group) |
Germany |
Jørgensen, Espen Tidemann (Holta Invest 2014– CEO of Holta Life Sciences joined Holta 2012) |
Chief Executive Officer (CEO) |
Holta Invest (Group) |
Norway |
Kabbaj, Meriam (Versantis AG 201704 COO + Co-Founder) |
Chief Executive Officer (CEO) |
Versantis AG |
Switzerland |
Kabel, Clemens (Berlin Capital Fund 200504 Senior Investment Manager) |
Investment Manager |
Triginta Capital (Group) |
Germany |
Kaeser, Joe (Siemens 200806 CFO) |
Chief Financial Officer (CFO) |
Siemens (Group) |
Germany |
Kaever, Volkhard (MHH 201110 Director Core Unit Mass Spectrometry/Metabolomics) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
MHH (Hanover Medical School / Medizinische Hochschule Hannover) |
Germany |
Kahl, Valentin |
Managing Director |
ibidi GmbH |
Germany |